1. A phase III study evaluating oral glutamine and transforming growth factor-beta 2 on chemotherapy-induced toxicity in patients with digestive neoplasm. Issue 3 (March 2016) Authors: Khemissa, Faïza; Mineur, Laurent; Amsellem, Caroline; Assenat, Eric; Ramdani, Mohamed; Bachmann, Patrick; Janiszewski, Chloé; Cristiani, Isabelle; Collin, Fideline; Courraud, Julie; de Forges, Hélène; Dechelotte, Pierre; Senesse, Pierre Journal: Digestive and liver disease Issue: Volume 48:Issue 3(2016) Page Start: 327 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
2. Applying ecological and evolutionary theory to cancer: a long and winding road. (16th November 2012) Authors: Thomas, Frédéric; Fisher, Daniel; Fort, Philippe; Marie, Jean‐Pierre; Daoust, Simon; Roche, Benjamin; Grunau, Christoph; Cosseau, Céline; Mitta, Guillaume; Baghdiguian, Stephen; Rousset, François; Lassus, Patrice; Assenat, Eric; Grégoire, Damien; Missé, Dorothée; Lorz, Alexander; Billy, Frédériqu... Journal: Evolutionary applications Issue: Volume 6:Number 1(2013) Page Start: 1 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
3. Autologous cell lines from circulating colon cancer cells captured from sequential liquid biopsies as model to study therapy-driven tumor changes. Issue 1 (December 2018) Authors: Soler, Alexandra; Cayrefourcq, Laure; Mazard, Thibault; Babayan, Anna; Lamy, Pierre-Jean; Assou, Said; Assenat, Eric; Pantel, Klaus; Alix-Panabières, Catherine Journal: Scientific reports Issue: Volume 8:Issue 1(2018) Page Start: 1 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
4. Bevacizumab plus FOLFIRI after failure of platinum–etoposide first-line chemotherapy in patients with advanced neuroendocrine carcinoma (PRODIGE 41-BEVANEC): a randomised, multicentre, non-comparative, open-label, phase 2 trial. Issue 3 (March 2023) Authors: Walter, Thomas; Lievre, Astrid; Coriat, Romain; Malka, David; Elhajbi, Farid; Di Fiore, Fréderic; Hentic, Olivia; Smith, Denis; Hautefeuille, Vincent; Roquin, Guillaume; Perrier, Marine; Dahan, Laetitia; Granger, Victoire; Sobhani, Iradj; Mineur, Laurent; Niccoli, Patricia; Assenat, Eric; Scoazec... Journal: Lancet oncology Issue: Volume 24:Issue 3(2023) Page Start: 297 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
5. Efficacy and safety of selective internal radiotherapy with yttrium-90 resin microspheres compared with sorafenib in locally advanced and inoperable hepatocellular carcinoma (SARAH): an open-label randomised controlled phase 3 trial. Issue 12 (December 2017) Authors: Vilgrain, Valérie; Pereira, Helena; Assenat, Eric; Guiu, Boris; Ilonca, Alina Diana; Pageaux, Georges-Philippe; Sibert, Annie; Bouattour, Mohamed; Lebtahi, Rachida; Allaham, Wassim; Barraud, Hélène; Laurent, Valérie; Mathias, Elodie; Bronowicki, Jean-Pierre; Tasu, Jean-Pierre; Perdrisot, Rémy; Si... Journal: Lancet oncology Issue: Volume 18:Issue 12(2017:Dec.) Page Start: 1624 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
6. Evaluating bevacizumab in combination with FOLFIRI after the failure of platinum-etoposide regimen in patients with advanced poorly differentiated neuroendocrine carcinoma: The PRODIGE 41–BEVANEC randomized phase II study. Issue 2 (February 2018) Authors: Walter, Thomas; Malka, David; Hentic, Olivia; Lombard-Bohas, Catherine; Le Malicot, Karine; Smith, Denis; Ferru, Aurélie; Assenat, Eric; Cadiot, Guillaume; Lievre, Astrid; Kurtz, Jean-Emmanuel; Dahan, Laetitia; Dubreuil, Olivier; Hautefeuille, Vincent; Lepere, Céline; Gangloff, Alice; Elhajbi, Fa... Journal: Digestive and liver disease Issue: Volume 50:Issue 2(2018) Page Start: 195 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
7. FOLFIRINOX for the treatment of colorectal cancer: latest evidence from clinical trials. (June 2012) Authors: Assenat, Eric Journal: Colorectal cancer Issue: Volume 1:Number 3(2012) Page Start: 181 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
8. Health-related quality of life in locally advanced hepatocellular carcinoma treated by either radioembolisation or sorafenib (SARAH trial). (September 2021) Authors: Pereira, Helena; Bouattour, Mohamed; Dioguardi Burgio, Marco; Assenat, Eric; Grégory, Jules; Bronowicki, Jean-Pierre; Chatellier, Gilles; Vilgrain, Valérie Journal: European journal of cancer Issue: Volume 154(2021) Page Start: 46 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
9. Health-related quality of life in locally advanced hepatocellular carcinoma treated by either radioembolisation or sorafenib (SARAH trial). (September 2021) Authors: Pereira, Helena; Bouattour, Mohamed; Burgio, Marco D.; Assenat, Eric; Grégory, Jules; Bronowicki, Jean-Pierre; Chatellier, Gilles; Vilgrain, Valérie; Assenat, Eric; Delhom-Christol, Elisabeth; Fourcade, Marjolène; Guiu, Boris; Ilonca, Alina Diana; Lonjon, Julie; Pageaux, Georges-Philippe; Abdel-R... Journal: European journal of cancer Issue: Volume 154(2021) Page Start: 46 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
10. Incidence of solid organ cancers after liver transplantation: comparison with regional cancer incidence rates and risk factors. (21st January 2015) Authors: Carenco, Christophe; Faure, Stéphanie; Herrero, Astrid; Assenat, Eric; Duny, Yohan; Danan, Guillaume; Bismuth, Michaël; Chanques, Gérald; Ursic‐Bedoya, José; Jaber, Samir; Larrey, Dominique; Navarro, Francis; Pageaux, Georges‐Philippe Journal: Liver international Issue: Volume 35:Number 6(2015:Jun.) Page Start: 1748 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗